Evidence from human and animal studies support the hypothesis that psychological stress can be a co-factor for the initiation and progression of cancer. Recent work from our laboratory and others have shown that the catecholamine hormone, norepinephrine (NE), may influence tumor progression of some solid epithelial tumors including nasopharyngeal carcinoma (NPC) and ovarian cancer by modulating the expression of proangiogenic and pro-metastatic factors, such as vascular endothelial growth factor (VEGF). In this study, we determined whether NE can likewise modulate the expression of VEGF in a lymphoid tumor, multiple myeloma (MM), a cancer of plasma cells. Three MM-derived cell lines, NCI-H929, MM-M1, and FLAM-76, were studied. The presence of b1-and b2-adrenergic receptors (ARs) was assessed using Western blotting. Cells were treated with 0, 1, and 10 lM NE for 1, 3, 6, and 24 h and the levels of VEGF in culture supernatants were measured by ELISA. Immunoblots of cell lysates revealed the presence of b1-and b2-ARs in all three MM-derived cell lines. However, these MM-derived cell lines exhibited varying degrees of NE-dependent regulation of VEGF expression with FLAM-76 (the only IL-6-dependent cell line among the three) exhibiting the most significant stimulation, followed by MM-M1 cells and then NCI-H929. The data suggest that the ability of NE to regulate the expression of VEGF is not limited to solid epithelial tumors and suggests a possible regulatory role of catecholamine stress hormones in MM progression.
Introduction
There is evidence that psychological factors can affect the incidence and progression of some cancers (KiecoltGlaser and Glaser, 1999; Lewis et al., 2002; Reiche et al., 2004) . The hypothesis that stress could be a co-factor is supported by data obtained from animal models (Riley, 1975; Saul et al., 2005) . Studies in the field of psychoneuroimmunology (PNI) have shown that psychological stress can induce endocrine-mediated dysregulation of many aspects of cellular immune function (including the inhibition of T-cell responses to tumor-associated antigens on tumor cells of immunogenic tumors); these interactions have been shown to be bi-directional (Ader, 2007; Padgett and Glaser, 2003; Rabin, 1999) .
There is now accumulating evidence to suggest that stress can also have effects that may contribute to tumor progression independent of its effects on the immune system (Lutgendorf et al., 2002 (Lutgendorf et al., , 2003 Sood et al., 2006; Yang et al., 2006) . Our work and that of others have shown that matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) are factors that can be modulated by catecholamine hormones. 
